Funded Tech Companies
Deciphera Pharmaceuticals
Wondering who provided funding to Deciphera Pharmaceuticals? New Leaf Venture Partners, Sphera Global Health Care Fund and Viking Global Investors joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Deciphera Pharmaceuticals
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
200 Smith St.
Waltham, MA 02451
USA
Waltham, MA 02451
USA
Phone
Website
Email Address
Company Background Information
Overview
Deciphera Pharmaceuticals (NASDAQ: DCPH) was established in 2003 as a drug discovery and development company with the mission to design, optimize and introduce best-in-class small molecule switch inhibitors of protein kinases for human clinical trials and the global pharmaceutical marketplace through the use of its proprietary drug discovery technology platform.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/27/2017
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Steven Hoerter
Chief Financial Officer
Tucker Kelly
Chief Scientific Officer
Daniel Flynn
VP - General Counsel
Jeffrey Held
VP - Human Resources
Peter Lasky
Company Investors
- New Leaf Venture Partners (Liam Ratcliffe)
- Sphera Global Health Care Fund
- Viking Global Investors
- Redmile Group
- SV Health Investors (Michael Ross)
- Kansas Technology Enterprise Corporation (Daniel Flynn)
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs